Evaluates autoantibody detection in systemic sclerosis using novel technology, indicating improved diagnostic approaches.
These findings support the diagnostic and clinical utility of comprehensive serological profiling and the integration of PMAT into routine diagnostic workflows. The identification of novel autoantibody-phenotype associations underscore the value of multiplex technologies in advancing precision medicine for SSc.
No takes yet. Share an insight, caveat, or question.
Pérez-Isidro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: